Kit ELISA Beta Secretase 1 sandwich (Hu BACE) (human): quantitative determination of Hu BACE in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu BACE.
Accession number
P56817
Dose range
1.024-250 ng/ml
Sensitivity of the dosage
1 ng
Calibration range
1.0 ng/ml to 250 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Beta Secretase 1 sandwich (Hu BACE) (human): quantitative determination of Hu BACE in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu BACE.
Kit ELISA Beta Secretase 1 sandwich (Hu BACE) (human): quantitative determination of Hu BACE in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu BACE.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The accumulation of amyloid b (Ab) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer's disease. Ab peptide is generated by proteolytic cleavage of the b-amyloid protein precursor (APP) at b- and g- sites by two proteases. L-APP is first cleaved by b-secretase, producing a soluble protein derivative and a carboxy end fragment (C99) of 99 amino acids anchored in the membrane. The C99 fragment serves as a substrate for g-secretase to generate the 4 kDa amyloid-b peptide, which is deposited in the brain of all people with Alzheimer's disease. Long-awaited b-secretase has recently been identified by several independent groups and designated by the beta-site cleavage enzyme (BACE) and aspartyl protease 2 (Asp2). bACE/Asp2 is a new aspartic transmembrane protease and co-located with APP.